Skip to content

ADSK

Autodesk, Inc.

NASDAQ · Technology · Software - Application · US

$217.90
−8.26%
Ask drillr

Research · Sep 3, 2026

[ADSK] Autodesk Thesis 2026: Direct Billing Transition Tests Margin Expansion Through GenAI Integration

Autodesk Inc. FY2025 revenue ~$6.1-6.3B (+10-12%) with adj. EPS ~$8.40-8.60 reflecting continued post-2023 transition to direct billing model from reseller (transformational ~$1B+ deferred revenue + ~$200-300M operating margin near-term headwind) + selected post-Starboard Value March 2024 activist campaign + selected delayed 10-K filing audit committee investigation Q3 2024 + selected GenAI integration ramp under continued CEO Andrew Anagnost. Leading global design + engineering + construction software firm; founded 1982 by John Walker + 12 other software developers in Marin County California originally as Autodesk Inc. (introduced AutoCAD 1982; IPO 1985 ~$60M raised); headquartered in San Francisco California; ~14,000+ employees across selected ~50+ countries; fiscal year ends ~January. ~$6.1-6.3B revenue. 3 end-market segments: Architecture, Engineering & Construction (AEC) 50% ($3.0-3.2B — Revit Building Information Modeling BIM + Civil 3D civil engineering + AutoCAD 2D drafting + Construction Cloud + BIM 360 + selected; selected #1 US/global market share in 2D drafting + 3D parametric modeling + BIM; ~30%+ operating margin) + Manufacturing 30% ($1.8-1.9B — Inventor 3D parametric modeling + Fusion 360 cloud-based CAD/CAM + Vault product data management; ~25-30% margin) + Media & Entertainment + Other 20% ($1.2-1.3B — Maya 3D animation + 3ds Max + Flame visual effects + selected gaming + film/TV; ~25-30% margin). CEO Andrew Anagnost since June 1, 2017 (succeeded Carl Bass CEO 2006-June 2017 retired; Anagnost ex-Autodesk CMO + Senior VP 2009-2017 + ~25-year Autodesk career joined 1997 as software engineer; Lockheed Aeronautical pre-Autodesk; Stanford PhD aerospace engineering). Direct billing transition: FY2024 announced transition from reseller model to direct billing for Enterprise Business Agreement customers; selected ~$1B+ deferred revenue + ~$200-300M near-term operating margin headwind FY2024-2025; selected post-transition steady-state economics expected to provide selected ~200-300 bps operating margin uplift + selected better customer relationship visibility + selected accelerated direct customer monetization. Pre-Anagnost CEO Carl Bass (CEO 2006-2017) led 2014-2017 transformational subscription transition. Anagnost tenure executed: 2017-2020 subscription transformation completion + 2020 COVID home renovation boom + 2021 Innovyze $1B (water management) + 2023 direct billing transition + March 2024 Starboard Value activist campaign (~$500M+ stake; selected board + operational pressure for cost cuts + capital return) + Q3 2024 delayed 10-K filing audit committee investigation (free cash flow accounting concerns; resolved no restatement) + 2024 selected ~9% workforce reduction (~1,300 employees) + selected GenAI integration. Capital return: no dividend policy; buybacks $1-1.5B (ramped post-Starboard); investment-grade A3/A- credit rating; net cash position ~$0-1B. FY2026 thesis: direct billing transition + GenAI integration + Starboard activism + capital return. Risks: AEC + manufacturing customer cycle, GenAI commoditization, competitive intensity (Bentley + Trimble + Adobe + Dassault).